Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The cryo-EM structure of the SNX-BAR Mvp1 tetramer
Grasas totales
Success rate this week Verification Activity Edwin Moore On Jul 24, 2026, Verified: Edwin Mooresaved $44.00 using this code Prof
The approval was granted under the FDAs National Priority Voucher programme, making it the fastest new molecular entity approval since 2002
Patients with cancer may develop gastroparesis because of chemotherapy-induced peripheral neuropathy, immunosuppression followed by viral infections involving the GI tract, procedures such as celiac blocks, paraneoplastic neuropathy or myopathy, or after an allogeneic bone marrow transplant via graft-versus-host disease
Saxenda reaches its maximum concentration in the body 11 hours after injection
US$ 25.94
US$ 27.41
